Zobrazeno 1 - 10
of 68
pro vyhledávání: '"B, Van Everbroeck"'
Publikováno v:
Clinical neurology and neurosurgery
Creutzfeldt-Jakob disease (CJD) is a rare neurodegenerative disorder. Since the emergence of variant CID (vCJD) vigilance concerning the disease's incidence has increased and the interest in accurate in vivo diagnosis has augmented. So far, a large n
Publikováno v:
Neurobiology of aging
In order to investigate inflammation and apoptosis in Creutzfeldt-Jakob disease (CJD) patients, we analyzed astrocytes, microglia and apoptotic neurons in brain and IL-1β in cerebrospinal fluid (CSF). Our results showed increased numbers of astrocyt
Autor:
B Van Everbroeck, J.J. Martin, C. Van Broeckhoven, Patrick Cras, Marc Cruts, U. Lübke, Raphael Sciot, H Backhovens, René Dom, Bart Dermaut
Publikováno v:
Journal of neurology
We describe a patient who was clinically diagnosed with familial early-onset Alzheimer disease (AD) carrying both the E318G substitution in presenilin 1 (PSEN1) and an insertion of 7 octapeptide coding repeats in the prion protein gene (PRNP). Neurop
Publikováno v:
Journal of Histochemistry & Cytochemistry. 47:1465-1470
SUMMARY Transmissible spongiform encephalopathies are a group of neurodegenerative diseases occurring in both humans and animals and are most likely caused by prions. Neuropathological confirmation of the clinical diagnosis has been a problem because
Publikováno v:
Journal of Alzheimer's Disease. 1:419-424
Creutzfeldt–Jakob disease (CJD) is a rare neurodegenerative disease caused by the prion protein. In the search for biochemical markers for CJD, cerebrospinal fluid (CSF) of 101 patients was analysed for 14-3-3 protein, hTau-protein and amyloid-beta
Autor:
Vittorio Mellina, J.-P. Brandel, Bettina Meissner, S. Almonti, Inga Zerr, Patrick Cras, Robert G. Will, Gerard H. Jansen, D. Collie, Steven J. Collins, Michael B. Coulthart, David Summers, B. Van Everbroeck, Kai Kallenberg, Damien Galanaud, Pascual Sánchez-Juan, Pete Smith, H. Roberts
Publikováno v:
Neurology
Neurology, 2009, 72 (23), pp.1994-2001. ⟨10.1212/WNL.0b013e3181a96e5d⟩
Neurology, American Academy of Neurology, 2009, 72 (23), pp.1994-2001. ⟨10.1212/WNL.0b013e3181a96e5d⟩
Neurology, 2009, 72 (23), pp.1994-2001. ⟨10.1212/WNL.0b013e3181a96e5d⟩
Neurology, American Academy of Neurology, 2009, 72 (23), pp.1994-2001. ⟨10.1212/WNL.0b013e3181a96e5d⟩
International audience; BACKGROUND: With respect to sporadic Creutzfeldt-Jakob disease (sCJD), six molecular subtypes (MM1, MM2, MV1, MV2, VV1, and VV2) have been described, which vary with respect to age at disease onset, disease duration, early sym
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db6a8841f31bd16d034a83bdf0ed6574
https://hal.inria.fr/hal-00805400
https://hal.inria.fr/hal-00805400
Autor:
R. Dom, Wim Robberecht, Philippe Pals, Patrick Cras, C. Laterre, J. J. Martin, Catherine Godfraind, Raphael Sciot, B Van Everbroeck
Publikováno v:
European Journal of Epidemiology. 15:517-519
Using data from Belgian neuropathological archives, completed with the results of a comprehensive study of available medical records, we found 100 patients who fulfilled diagnostic criteria for probable or definite Creutzfeldt-Jakob d1551isease (CJD)
Autor:
Hugo M. Vanderstichele, S. Engelborghs, K. De Vreese, T. Van de Casteele, B. Van Everbroeck, P. Cras, J.-J. Martin, P. De Deyn, Eugeen Vanmechelen
Publikováno v:
Alzheimer's & Dementia. 2
Autor:
Patrick Cras, Manuel Deprez, Alex Michotte, B Van Everbroeck, C Godfraind, Raphael Sciot, Sophie Quoilin, J. J. Martin
Publikováno v:
European journal of epidemiology
From 1998 a prospective surveillance study of Creutzfeldt-Jakob disease (CJD) has been initiated in Belgium. In addition to epidemiological data, information on cerebrospinal fluid biomarkers, prion protein gene and brain neuropathology was collected
Publikováno v:
Journal of neurology, neurosurgery and psychiatry
We developed a polyclonal antiserum directed to the gamma-isoform of the human 14-3-3 protein and compared the immunoreactivity with a commercially available antibody (CG31). We analysed 14-3-3 in 253 cerebrospinal fluid samples blinded for the diagn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c91db5438189ad3f96a1b3aec61314
https://europepmc.org/articles/PMC1739297/
https://europepmc.org/articles/PMC1739297/